[1]
|
Powell, E.E., Wong, V.W. and Rinella, M. (2021) Non-Alcoholic Fatty Liver Disease. The Lancet, 397, 2212-2224.
https://doi.org/10.1016/S0140-6736(20)32511-3
|
[2]
|
Younossi, Z.M., Noureddin, M., Bernstein, D., et al. (2021) Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients with Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations. American Journal of Gastroenterology, 116, 254-262. https://doi.org/10.14309/ajg.0000000000001054
|
[3]
|
Torres-Peña, J.D., Arenas-De Larriva, A.P., Alcala-Diaz, J.F., et al. (2023) Different Dietary Approaches, Non-Alco- holic Fatty Liver Disease and Cardiovascular Disease: A Literature Review. Nutrients, 15, Article No. 1483.
https://doi.org/10.3390/nu15061483
|
[4]
|
Zhou, J., Zhou, F., Wang, W., et al. (2020) Epidemiological Features of NAFLD from 1999 to 2018 in China. Hepatology, 71, 1851-1864. https://doi.org/10.1002/hep.31150
|
[5]
|
Eslam, M., Sanyal, A.J. and George, J. (2020) MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associat-ed Fatty Liver Disease. Gastroenterology, 158, 1999-2014.e1. https://doi.org/10.1053/j.gastro.2019.11.312
|
[6]
|
McGlinchey, A.J., Govaere, O., Geng, D., et al. (2022) Metabol-ic Signatures across the Full Spectrum of Non-Alco- holic Fatty Liver Disease. JHEP Reports, 4, Article ID: 100477. https://doi.org/10.1016/j.jhepr.2022.100477
|
[7]
|
Gofton, C., Upendran, Y., Zheng, M.H., et al. (2023) MAFLD: How Is It Different from NAFLD? Clinical and Molecular Hepatology, 29, S17-S31. https://doi.org/10.3350/cmh.2022.0367
|
[8]
|
Harrison, S.A., Ratziu, V., Boursier, J., et al. (2020) A Blood-Based Biomarker Panel (NIS4) for Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis and Liver Fibrosis: A Prospective Derivation and Global Validation Study. The Lancet Gastroenterology and Hepatology, 5, 970-985. https://doi.org/10.1016/S2468-1253(20)30252-1
|
[9]
|
Stefan, N. and Cusi, K. (2022) A Global View of the Inter-play between Non-Alcoholic Fatty Liver Disease and Diabetes. The Lancet Diabetes & Endocrinology, 10, 284-296. https://doi.org/10.1016/S2213-8587(22)00003-1
|
[10]
|
Ezpeleta, M., Gabel, K., Cienfuegos, S., et al. (2023) Alter-nate-Day Fasting Combined with Exercise: Effect on Sleep in Adults with Obesity and NAFLD. Nutrients, 15, Article No. 1398. https://doi.org/10.3390/nu15061398
|
[11]
|
En Li Cho, E., Ang, C.Z., Quek, J., et al. (2023) Global Prev-alence of Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: An Updated Systematic Review and Me-ta-Analysis. Gut, 72, 2138-2148.
https://doi.org/10.1136/gutjnl-2023-330110
|
[12]
|
Allen, A.M., Lazarus, J.V. and Younossi, Z.M. (2023) Healthcare and Socioeconomic Costs of NAFLD: A Global Framework to Navigate the Uncertainties. Journal of Hepatology, 79, 209-217.
https://doi.org/10.1016/j.jhep.2023.01.026
|
[13]
|
中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病防治指南(2018年更新版) [J]. 临床肝胆病杂志, 2018, 34(5): 947-957. https://doi.org/10.3969/J.Issn.1001-5256.2018.05.007
|
[14]
|
Weisell, R.C. (2002) Body Mass Index as an Indicator of Obesity. Asia Pacific Journal of Clinical Nutrition, 11, S681- S684. https://doi.org/10.1046/j.1440-6047.11.s8.5.x
|
[15]
|
Peng, H., Pan, L., Ran, S., et al. (2023) Prediction of MAFLD and NAFLD Using Different Screening Indexes: A Cross-Sectional Study in U.S. Adults. Frontiers in Endocrinology (Lausanne), 14, Article ID: 1083032.
https://doi.org/10.3389/fendo.2023.1083032
|
[16]
|
He, Y., Su, Y., Duan, C., et al. (2023) Emerging Role of Aging in the Progression of NAFLD to HCC. Ageing Research Reviews, 84, Article ID: 101833. https://doi.org/10.1016/j.arr.2022.101833
|
[17]
|
Mao, T., Sun, Y., Xu, X., et al. (2023) Overview and Prospect of NAFLD: Significant Roles of Nutrients and Dietary Patterns in Its Progression or Prevention. Hepatology Communica-tions, 7, e0234.
https://doi.org/10.1097/HC9.0000000000000234
|
[18]
|
陈红, 赵莎莎, 杨婉君. 河南省焦作市高校新生膳食及生活行为方式与非酒精性脂肪肝的关系[J]. 实用预防医学, 2022, 29(9): 1115-1118. https://doi.org/10.3969/J.Issn.1006-3110.2022.09.023
|
[19]
|
杜秋菊, 束龙, 叶翔, 等. 杭州市6所高校大学新生膳食模式与非酒精性脂肪肝的关系[J]. 中国学校卫生, 2019, 40(3): 434-436+440. https://doi.org/10.16835/J.Cnki.1000-9817.2019.03.032
|
[20]
|
Liu, X., Peng, Y., Chen, S., et al. (2018) An Obser-vational Study on the Association between Major Dietary Patterns and Non-Alcoholic Fatty Liver Disease in Chinese Adolescents. Medicine (Baltimore), 97, e0576.
https://doi.org/10.1097/MD.0000000000010576
|
[21]
|
祁生贵, 更登, 李莉, 等. 非酒精性脂肪性肝病在不同海拔及不同民族人群中的患病率[J]. 环境卫生学杂志, 2022, 12(7): 533-536. https://doi.org/10.13421/J.Cnki.Hjwsxzz.2022.07.011
|
[22]
|
蔡浩. 慢性低氧对小鼠非酒精性脂肪肝炎的调控机制研究[D]: [博士学位论文]. 青海: 青海大学, 2022.
|
[23]
|
Dolce, A. and Della Torre, S. (2023) Sex, Nutrition, and NAFLD: Relevance of Environmental Pollution. Nutrients, 15, Article No. 2335. https://doi.org/10.3390/nu15102335
|
[24]
|
Pan, Y. and Zhang, X. (2022) Diet and Gut Microbiome in Fatty Liver and Its Associated Liver Cancer. Journal of Gastroenterology and Hepatology, 37, 7-14. https://doi.org/10.1111/jgh.15713
|
[25]
|
Yahoo, N., Dudek, M., Knolle, P., et al. (2023) Role of Immune Responses in the Development of NAFLD-Associated Liver Cancer and Prospects for Therapeutic Modulation. Journal of Hepa-tology, 79, 538-551.
https://doi.org/10.1016/j.jhep.2023.02.033
|
[26]
|
Glass, O., Filozof, C., Noureddin, M., et al. (2020) Standardisation of Diet and Exercise in Clinical Trials of NAFLD- NASH: Recommendations from the Liver Forum. Journal of Hepa-tology, 73, 680-693.
https://doi.org/10.1016/j.jhep.2020.04.030
|
[27]
|
Semmler, G., Datz, C., Reiberger, T., et al. (2021) Diet and Exer-cise in NAFLD/NASH: Beyond the Obvious. Liver International, 41, 2249-2268. https://doi.org/10.1111/liv.15024
|
[28]
|
Jensen, T., Abdelmalek, M.F., Sullivan, S., et al. (2018) Fructose and Sugar: A Major Mediator of Non-Alcoholic Fatty Liver Disease. Journal of Hepatology, 68, 1063-1075. https://doi.org/10.1016/j.jhep.2018.01.019
|
[29]
|
Coronati, M., Baratta, F., Pastori, D., et al. (2022) Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review. Nutrients, 14, Article No. 1127. https://doi.org/10.3390/nu14061127
|
[30]
|
Softic, S., Stanhope, K.L., Boucher, J., et al. (2020) Fructose and Hepatic Insulin Resistance. Critical Reviews in Clinical Laboratory Sciences, 57, 308-322. https://doi.org/10.1080/10408363.2019.1711360
|
[31]
|
Xu, R., Pan, J., Zhou, W., et al. (2022) Recent Advances in Lean NAFLD. Biomedicine & Pharmacotherapy, 153, Article ID: 113331. https://doi.org/10.1016/j.biopha.2022.113331
|
[32]
|
Nabi, O., Lapidus, N., Boursier, J., et al. (2023) Lean Individu-als with NAFLD Have More Severe Liver Disease and Poorer Clinical Outcomes (NASH-CO Study). Hepatology, 78, 272-283.
https://doi.org/10.1097/HEP.0000000000000329
|
[33]
|
Xu, C., Ma, Z., Wang, Y., et al. (2018) Visceral Adiposity Index as a Predictor of NAFLD: A Prospective Study with 4-Year Follow-Up. Liver International, 38, 2294-2300. https://doi.org/10.1111/liv.13941
|
[34]
|
Tang, M., Wei, X.H., Cao, H., et al. (2022) Association between Chinese Visceral Adiposity Index and Metabolic- Associated Fatty Liver Disease in Chinese Adults with Type 2 Diabetes Melli-tus. Frontiers in Endocrinology (Lausanne), 13, Article ID: 935980. https://doi.org/10.3389/fendo.2022.935980
|
[35]
|
Ismaiel, A., Jaaouani, A., Leucuta, D.C., et al. (2021) The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis. Bio-medicines, 9, Article No. 1890.
https://doi.org/10.3390/biomedicines9121890
|